Page last updated: 2024-08-26

terameprocol and everolimus

terameprocol has been researched along with everolimus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chao, A; Chen, SJ; Lai, CH; Lee, LY; Lee, YS; Lin, CY; Liu, H; Tsai, CL; Wang, TH; Wu, RC; Yang, LY	1

Other Studies

1 other study(ies) available for terameprocol and everolimus

Article	Year
The combination of everolimus and terameprocol exerts synergistic antiproliferative effects in endometrial cancer: molecular role of insulin-like growth factor binding protein 2. Journal of molecular medicine (Berlin, Germany), 2018, Volume: 96, Issue:11 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Endometrial Neoplasms; Everolimus; Female; Humans; Immunosuppressive Agents; Insulin-Like Growth Factor Binding Protein 2; Masoprocol; Mice, Inbred BALB C; Mice, Nude; PTEN Phosphohydrolase	2018

Article

Year

The combination of everolimus and terameprocol exerts synergistic antiproliferative effects in endometrial cancer: molecular role of insulin-like growth factor binding protein 2.

Journal of molecular medicine (Berlin, Germany), 2018, Volume: 96, Issue:11

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Endometrial Neoplasms; Everolimus; Female; Humans; Immunosuppressive Agents; Insulin-Like Growth Factor Binding Protein 2; Masoprocol; Mice, Inbred BALB C; Mice, Nude; PTEN Phosphohydrolase

2018